The SFDA participated in the workshop of "New Guidelines for Development and Approval of Bioequivalent products" which took place in Paris on the 8th to 9th of December 2005 which supported by the European Agency for Drug Evaluation in contribution with the Drug Union. Dr Mohammad Al Ahdal, member of the consulting committee of drug sector and president of team which responsible for guidance of biological products is the one who represent the SFDA in this international symposium.